Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in miceMorgan, B. P. ; Chamberlain‐Banoub, J. ; Neal, J. W. ; Song, W. ; Mizuno, M. ; Harris, C. L.Clinical and experimental immunology, 2006-11, Vol.146 (2), p.294-302 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis ratsChamberlain‐Banoub, J. ; Neal, J. W. ; Mizuno, M. ; Harris, C. L. ; Morgan, B. P.Clinical and experimental immunology, 2006-11, Vol.146 (2), p.278-286 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Conditioned Place Preference and Locomotor Sensitization after Repeated Administration of Cocaine or Methamphetamine in Rats Treated with Epidermal Growth Factor during the Neonatal PeriodMIZUNO, MAKOTO ; MALTA JR, ROMULO S. ; NAGANO, TADASATO ; NAWA, HIROYUKIAnnals of the New York Academy of Sciences, 2004-10, Vol.1025 (1), p.612-618 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
The role of C5a in the development of thrombotic glomerulonephritis in ratsKondo, C. ; Mizuno, M. ; Nishikawa, K. ; Yuzawa, Y. ; Hotta, N. ; Matsuo, S.Clinical and experimental immunology, 2001-05, Vol.124 (2), p.323-329 [Periódico revisado por pares]Oxford, UK: Blackwell Science LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59MIZUNO, M ; NISHIKAWA, K ; MORGAN, B. P ; MATSUO, SClinical and experimental immunology, 2000-02, Vol.119 (2), p.368-375 [Periódico revisado por pares]Oxford BSL: Blackwell Science LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Cytokine‐stimulated release of decay‐accelerating factor (DAF; CD55) from HT‐29 human intestinal epithelial cellsNASU, J ; MIZUNO, M ; TSUJI, T ; UESU, T ; TAKEUCHI, K ; INABA, T ; OHYA, S ; KAWADA, M ; SHIMO, K ; OKADA, H ; FUJITA, TClinical and experimental immunology, 1998-09, Vol.113 (3), p.379-385 [Periódico revisado por pares]Oxford BSL: Blackwell Science LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC)UEKI, T. ; MIZUNO, M. ; UESU, T. ; KISO, T. ; NASU, J. ; INABA, T. ; KIHARA, Y. ; MATSUOKA, Y. ; OKADA, H. ; FUJITA, T. ; TSUJI, T.Clinical and experimental immunology, 1996-05, Vol.104 (2), p.286-292 [Periódico revisado por pares]Oxford BSL: Blackwell Science LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
Complement and complement regulators in the male reproductive systemHarris, Claire L. ; Mizuno, Masashi ; Morgan, B. PaulMolecular Immunology, 2006, Vol.43 (1), p.57-67 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
High frequency of circulating HBcAg‐specific CD8 T cells in hepatitis B infection: a flow cytometric analysisMatsumura, S. ; Yamamoto, K. ; Shimada, N. ; Okano, N. ; Okamoto, R. ; Suzuki, T. ; Hakoda, T. ; Mizuno, M. ; Higashi, T. ; Tsuji, T.Clinical and experimental immunology, 2001-06, Vol.124 (3), p.435-444 [Periódico revisado por pares]Oxford, UK: Blackwell Science LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Decay‐accelerating factor (DAF) in stool specimens as a marker of disease activity in patients with ulcerative colitis (UC)INABA, T ; MIZUNO, M ; TSUJI, T ; OHYA, S ; KAWADA, M ; UESU, T ; NASU, J ; TAKEUCHI, K ; NAKAGAWA, M ; OKADA, H ; FUJITA, TClinical and experimental immunology, 1998-05, Vol.112 (2), p.237-241 [Periódico revisado por pares]Oxford BSL: Blackwell Science LtdTexto completo disponível |